Report Highlights
The global clinical infant nutrition market reached $44.8 billion in 2021 and should reach more than $61.5 billion by 2026, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2021-2026.
Report Includes
- 17 data tables and 32 additional tables
- An up-to-date overview and analysis of the global market for clinical infant nutrition
- Analyses of the global market trends, with historical sales data for 2018-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the current and future market potential for clinical infant nutrition, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the clinical infant nutrition market size, projected growth trends, and corresponding market share analysis segmented by nutrition type, formulation technique, product form, and geographic region
- Assessment of major driving factors, trends, opportunities and challenges in this innovation driven market, along with technology advances and regulatory implications within the marketplace
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
- Company profiles of major players within the industry, including Abbott Laboratories, Baxter International Inc., Danone, Fresenius, Nestlé, and Reckitt Benckiser Group Plc
Report Scope
The current report will provide detailed information regarding the infant nutrition market. It analyzes the market trends of infant nutrition with data from 2020, estimates from 2021, projections of compound annual growth rates (CAGR) through 2026 (i.e., forecast period 2021 through 2026) and regional markets of infant nutrition devices. This report will highlight the current and future market potential for infant nutrition, as well as a detailed analysis of the competitive environment. It report will cover regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2026 and the market shares for key market players.
Based on infant formulas, the market is segmented into specialized infant formulas and standard infant formulas. Based on nutrition type, the market is segmented into enteral and parenteral nutrition. The market is also segmented by powdered formula, concentrated liquid formula and ready-to-use formula.
The market has been segmented into various major geographic regions, including North America, Europe, Asia-Pacific and the Rest of the World. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Japan, China, India) will be covered within the regional segment. For market estimates, data are provided using 2020 as the base year, with estimates for 2021 and forecast value for 2026.
A holistic study of the market has been carried out, incorporating various factors, including country-specific demographic conditions and business cycles, and market-specific microeconomic influences needed to analyze future market trends. Key vendor analysis, new products, developments and financials are also provided to enable easy decision making.
Report Synopsis
Report Metrics | Details | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2020 | ||||||||||||||||||||||||||||
Forecast period considered | 2021–2026 | ||||||||||||||||||||||||||||
Base year market size | $44.4 billion | ||||||||||||||||||||||||||||
Market size forecast | $61.5 billion | ||||||||||||||||||||||||||||
Growth rate | CAGR of 6.5% from 2021 to 2026 | ||||||||||||||||||||||||||||
Units considered | $ Millions | ||||||||||||||||||||||||||||
Segments covered | Type Of Infant Formula, Type Of Nutrition, Form | ||||||||||||||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||
Countries covered | U.S., Canada, Germany, U.K., France, Italy, Spain, Rest of Europe, China, India, Japan, Australia, South Korea, Rest of Asia-Pacific | ||||||||||||||||||||||||||||
Key Market Drivers |
|
||||||||||||||||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- AI Impact on Bioseparation Systems Market - BCC Pulse Report (AIT055A)
- AI Impact on Tissue Engineering and Regeneration Market–BCC Pulse Report (AIT052A)
- Wood Waste Recycling: Global Markets (ENV074A)
- AI in Neurology: Global Markets (AIT018A)
- Separation Systems for Commercial Biotechnology (BIO011H)
Related Reports
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Sports Nutrition and High Energy Supplements: The Global Market
The global market for sports nutrition and high-energy supplements is estimated to increase from $37.0 billion in 2023 to reach $53.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Personalized Nutrition: Global Markets
The global personalized nutrition market reached $23.5 billion in 2022 and should reach $48.2 billion by 2028, with a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2023-2028.
Functional Foods and Beverages: Global Markets
The global market for functional food and beverages should grow from $216.4 billion in 2022 to $324.4 billion by 2027 with a compound annual growth rate (CAGR) of 8.4% for the period of 2022-2027.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Brain Tumor Therapeutics: Global Markets to 2030
The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.
Global Viral Vector Manufacturing Markets and Technologies Through 2030
The global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.
Hyaluronic Acid in Healthcare: Global Markets
The global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.
Targeted Alpha Therapies for Cancer Treatment: Global Market
This report provides an overview of the global market for targeted alpha therapies for cancer and analyses market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.
Therapies for Rheumatoid Arthritis: Technologies and Global Markets
The global market for rheumatoid arthritis therapies was valued at $28.5 billion in 2024 and is estimated to increase from $30.2 billion in 2025 to reach $41.1 billion by 2030, at a compound annual growth rate (CAGR) of 6.3% from 2025 through 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More